Moreover, studies in an animal model of AD have shown that in APP/PS1 transgenic mice, AQP4 deletion exacerbates cognitive deficits and is associated with an increase in Aβ accumulation [39]. This evidence concerns the gene AQP4 and Alzheimer disease.